Continue Reading Post >

Latest Tweets

Modulating the frequency of ITAMs on #TCell receptors could increase the safety of CAR-T cell therapies… https://t.co/ywc3cZPLP6
25th May, 2018
Advancing your #TCell Program while keeping commercialization in mind is no easy feat. Let us help you!… https://t.co/PXYtPqpP2s
25th May, 2018
The evidence is increasing that #naive T cells are heterogeneous in phenotype, function, dynamics and differentiati… https://t.co/WjI6jV1QU2
25th May, 2018
#CTA_journal published a study that provides new insights about  #Tcell research in # lymphoid tissue… https://t.co/Rnq86oLxWG
25th May, 2018
Spotlight: (Original article appears in @AACR Clinical Cancer Research https://t.co/JMnBuHy3Jx) @UFHealthhttps://t.co/n6LopZdNbU
24th May, 2018
The cancer assassin : how does a killer T cell kill its target ? https://t.co/7fM6K8YxWx 2015 video via… https://t.co/vvRZfY9AEq
24th May, 2018